Benzinga | Sep 23, 2021 07:36AM EDT

JonesTrading Initiates Coverage On Landos Biopharma with Buy Rating, Announces Price Target of $39

JonesTrading analyst Prakhar Agrawal initiates coverage on Landos Biopharma (NASDAQ:LABP) with a Buy rating and announces Price Target of $39.